Chesnara chooses Liberata as outsourcing partner
On 6 July, announcements were made by both Chesnara and Marlborough Stirling
that Marlborough Stirling had been selected as preferred outsourcing supplier
to Chesnara, subject to completion of due diligence and contract negotiation.
After the announcement was made in July, Liberata, another leading UK
outsourcer, with which Chesnara had already been in discussions, approached
Chesnara and put forward an improved proposal. In the light of its obligations
to shareholders the Company felt it right to explore this proposal.
As a result, extensive negotiations have taken place with both parties, which
has enabled Chesnara to choose between two competing propositions. The
assessment process has included two-way due diligence, definition of scope and
re-negotiation of terms.
The board of Chesnara decided to accept the final proposal put forward by
Liberata as it contained the best balance of economic terms, expertise and
track record of service delivery.
The financial terms are in line with the renewal expense assumptions currently
included in Chesnara's embedded value and will have no material impact on this
year's earnings or the group's short-term dividend paying capability.
Approximately 180 Chesnara employees, who will continue to occupy existing
premises in Preston, will shortly transfer to Liberata under the arrangements.
Graham Kettleborough, Chief Executive of Chesnara, said:
'With two strong competitors, we have been able to choose the best solution for
the Company and its shareholders. Liberata has an excellent track record in the
industry, working with leading clients such as Barclays, Axa and Save &
Prosper.'
Tom Butler, Chief Executive of Liberata, said:
'We see Chesnara as a key strategic partner for us in the UK, and we are
delighted to have been selected and to be able to support them moving forward.
It enables us to further extend our leading position in the UK outsourcing life
market.
'Liberata is already the equivalent of a top ten life company in terms of
policies administered and this partnership emphasises our market leading
capability.'
Enquiries
Graham Kettleborough 01772 840001
Chief Executive, Chesnara plc 07799 407519
Michael Henman 020 7367 5106
Director, Cubitt Consulting 07740 038930
Chris Boon 0208 666 9101
Business Development Director, Liberata UK Ltd. 07860 589202
Notes to editors:
Chesnara plc, which was listed on the London Stock Exchange on 25 May 2004, was
formed to become the new holding company of the life assurance activities
formerly owned by Countrywide Assured Group plc. Although substantially closed
to new business it continues to write Guaranteed Income and Growth Bonds and a
small amount of protection policies to existing customers.
Liberata plc (www.liberata.com) is one of the UK's leading providers of
outsourced business processes, liberating clients and employees, creating
exceptional opportunities both for them and shareholders.
Through its driven leadership and intense performance environment, Liberata
transforms operations, reducing the cost of in-house services and delivering
greater efficiency and effectiveness through its six sigma methodology,
allowing clients to focus on their core activities.
Liberata currently employs approximately 4,000 people in 25 business centres
across the UK.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.